Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesCytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival
European Journal of Surgical Oncology, 07/01/09
Hagendoorn J et al. - In a study to examine the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal carcinomatosis of colorectal and gastrointestinal origin, it was concluded that in well-selected pts referred to a specialized institution, CS–HIPEC has acceptable morbidity and high survival rate.
Methods- 67 pts underwent a laparotomy.
- Complete cytoreduction could be performed in 49 pts, who underwent 53 CS–HIPEC procedures.
- All had peritoneal carcinomatosis originating from primary colorectal, cecal, appendiceal, and gastric tumors.
- In pts who underwent CS–HIPEC, an R0 resection could be achieved in 4%, R1 in 88%, and R2 in 8%.
- 30-day mortality was 0; 1 pt died in-hospital after 10 wks.
- Median hospital stay was 12 days.
- Overall morbidity was 43%, including extended gastroparesis (11%), anastomotic failure (11%), and intra-abdominal abscess (9%).
- Mean time to clinical recurrence was 12 mos.
- Actuarial 1-yr survival was 88% and 2-yr survival was 75%.
Related Articles
Combined chemotherapy with carboplatin plus irinotecan showed favorable efficacy in a patient with relapsed small cell carcinoma of the prostate complicated with meningeal carcinomatosis
International Journal of Clinical Oncology, 10/30/09
Relevance Score: 84%
KAP1 Is Associated With Peritoneal Carcinomatosis in Gastric Cancer
Annals of Surgical Oncology, 11/11/09
Relevance Score: 83%
Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection
European Journal of Surgical Oncology, 11/17/09
Relevance Score: 80%
Noninternalizing Monoclonal Antibodies Are Suitable Candidates for 125I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis
The Journal of Nuclear Medicine, 11/16/09
Relevance Score: 80%
Peritoneal carcinomatosis from ovarian cancer: the role of CT and [18F]FDG-PET/CT
Abdominal Imaging, 10/01/09
Relevance Score: 80%
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression
Genes, Chromosomes and Cancer, 12/19/09
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/18/09
Sunlight, hormone replacement status and colorectal cancer risk in postmenopausal women
International Journal of Cancer, 12/18/09
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/18/09
Anemia response and safety to epoetin-beta treatment in patients with neoadjuvant therapy prior to primary digestive tract tumor surgery
Cancer Chemotherapy and Pharmacology, 12/17/09
Decreased expression of KLF6 and its significance in gastric carcinoma
Medical Oncology, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor